We would like to inform you about the financial support provided by the participating companies in accordance with their membership in the FSA e.V. (Voluntary Self-Regulation for the Pharmaceutical Industry e.V.), in the AKG e.V. (Pharmaceuticals and Cooperation in Healthcare) or because the companies have approved the publication.
Regardless of the aforementioned memberships, the terms and scope of financial support from all companies and specialist publishers involved in the event will be published if the professional code of conduct of the responsible medical association requires it.
This is also based on the recommendations of the German Medical Association on medical training, 4th revised edition, as of April 24, 2015, p.11 ff, § 32 para. 3 MBO, § 8 para. 1 no. 3 MFO.

As of: 2026-03-31

Abbvie Deutschland GmbH & Co. KG €5,000 | Alfasigma GmbH €5,000 | AMBU GmbH €20,250 | AstraZeneca GmbH €5,000 | BeOne Medicines Germany GmbH €5,000 | Boston Scientific Medizintechnik GmbH €31,500 | Cook Deutschland GmbH €5,000 | Dr. Falk Pharma GmbH €15,000 | Endo-Flex GmbH / Medi-Globe GmbH €7,500 | ERBE Elektromedizin GmbH €15,750 | Fresenius Kabi Deutschland GmbH €11,750 | FUJIFILM Healthcare Deutschland GmbH €31,500 | Johnson & Johnson, Janssen-Cilag GmbH €10,000 | Lilly Deutschland GmbH €5,000 | Medtronic GmbH €17,500 | Micro-Tech Europe GmbH €30,750 | MSD Sharp & Dohme GmbH €1,500 | Norgine GmbH €750 | Olympus Deutschland GmbH €15,750 | Ovesco Endoscopy AG €10,500 | Pentax Europe GmbH €8,000 | Sanofi-Aventis Deutschland GmbH €1,750 | SonoScape Medical Germany GmbH €5,000 | Standard Instruments GmbH €4,000 | Takeda Pharma Vertrieb GmbH & Co. KG €5,000

The contents of the congress are product and service neutral. There are no conflicts of interest on the part of the organizer. There are conflicts of interest on the part of the scientific management and the speakers; these will be disclosed.
The supporting program is not financed by the sponsorship money.